Aythya fuligula isolate bAytFul2 chromosome 8, bAytFul2.pri, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Anseriformes; Anatidae; Aythyinae; Aythya.
REFSEQ INFORMATION: The reference sequence is identical to\nCM020307.1.\nAssembly name: bAytFul2.pri\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2019/12/31. The original whole-genome shotgun project has the\naccession WNMM00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2019\nAssembly Method :: FALCON v. 2018.31.08-03.06; FALCON-Unzip\n v. 6.0.0.47841; purge_haplotigs v.\n v1.0.3+ 1.Nov.2018; scaff10x v. 4.1.0;\n Bionano Solve DLS v. 3.2.1; Salsa HiC v.\n 2.2; Arrow smrtanalysis Pacbio polishing\n & gap filling v. 6.0.0.47841; longranger\n align v. 2.2.2; freebayes Illumina\n polishing v. 1.3; gEVAL manual curation\n v. 2019-09-20; VGP assembly pipeline\n individual v. 1.5\nAssembly Name :: bAytFul2.pri\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 64.03x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Aythya fuligula Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.3\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Patrik Ellstrom, Mahmoud Naguib, Josef Jarhult
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC116492239, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC116492239, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC116492239, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Rab geranylgeranyltransferase subunit beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
geranylgeranyl transferase type-2 subunit beta
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00279
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tRNA wybutosine-synthesizing protein 3 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger Ran-binding domain-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat domain-containing protein 13C
serine and arginine rich splicing factor 11
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: serine/arginine-rich splicing factor 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeat-containing protein 40
leucine rich repeat containing 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine rich repeat containing 7, transcript variant X3
leucine rich repeat containing 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine rich repeat containing 7, transcript variant X1
leucine rich repeat containing 7, transcript variant X2
leucine-rich repeat-containing protein 7 isoform X4
leucine-rich repeat-containing protein 7 isoform X2
leucine-rich repeat-containing protein 7 isoform X3
leucine-rich repeat-containing protein 7 isoform X1
leucine rich repeat containing 7, transcript variant X6
leucine-rich repeat-containing protein 7 isoform X5
leucine rich repeat containing 7, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat-containing protein 7 isoform X6
leucine rich repeat containing 7, transcript variant X9
leucine-rich repeat-containing protein 7 isoform X8
leucine rich repeat containing 7, transcript variant X8
leucine-rich repeat-containing protein 7 isoform X7
DEP domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DEP domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DEP domain-containing protein 1A isoform X1
DEP domain-containing protein 1A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
methylcrotonoyl-CoA carboxylase beta chain, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
G protein subunit gamma 12, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
G protein subunit gamma 12, transcript variant X2
G protein subunit gamma 12, transcript variant X3
G protein subunit gamma 12, transcript variant X1
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 isoform X1
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 isoform X2
growth arrest and DNA damage inducible alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
growth arrest and DNA damage-inducible protein GADD45 alpha
SERPINE1 mRNA binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SERPINE1 mRNA binding protein 1, transcript variant X2
plasminogen activator inhibitor 1 RNA-binding protein isoform X1
plasminogen activator inhibitor 1 RNA-binding protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: interleukin-12 receptor subunit beta-2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 58% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter
MIER1 transcriptional regulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
MIER1 transcriptional regulator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mesoderm induction early response protein 1 isoform X1
mesoderm induction early response protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SH3GL interacting endocytic adaptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SH3GL interacting endocytic adaptor 1, transcript variant X2
SH3GL interacting endocytic adaptor 1, transcript variant X3
SH3GL interacting endocytic adaptor 1, transcript variant X6
SH3GL interacting endocytic adaptor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SH3GL interacting endocytic adaptor 1, transcript variant X4
SH3-containing GRB2-like protein 3-interacting protein 1 isoform X4
SH3-containing GRB2-like protein 3-interacting protein 1 isoform X3
SH3-containing GRB2-like protein 3-interacting protein 1 isoform X2
SH3-containing GRB2-like protein 3-interacting protein 1 isoform X1
phosphodiesterase 4B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphodiesterase 4B, transcript variant X2
phosphodiesterase 4B, transcript variant X3
cAMP-specific 3',5'-cyclic phosphodiesterase 4B isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4B isoform X2
cAMP-specific 3',5'-cyclic phosphodiesterase 4B isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member C6, transcript variant X2
DnaJ heat shock protein family (Hsp40) member C6, transcript variant X1
putative tyrosine-protein phosphatase auxilin isoform X2
putative tyrosine-protein phosphatase auxilin isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
VWFA and cache domain-containing protein 1
receptor tyrosine kinase like orphan receptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
receptor tyrosine kinase like orphan receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inactive tyrosine-protein kinase transmembrane receptor ROR1 isoform X1
inactive tyrosine-protein kinase transmembrane receptor ROR1 isoform X2
EF-hand calcium binding domain 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
EF-hand calcium binding domain 7, transcript variant X1
EF-hand calcium-binding domain-containing protein 7
integrin subunit beta 3 binding protein, transcript variant X1
integrin subunit beta 3 binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
autophagy related 4C cysteine peptidase, transcript variant X1
autophagy related 4C cysteine peptidase, transcript variant X2
dedicator of cytokinesis 7, transcript variant X1
dedicator of cytokinesis 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dedicator of cytokinesis 7, transcript variant X3
dedicator of cytokinesis 7, transcript variant X4
dedicator of cytokinesis 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dedicator of cytokinesis 7, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dedicator of cytokinesis protein 7 isoform X1
dedicator of cytokinesis protein 7 isoform X2
dedicator of cytokinesis protein 7 isoform X3
dedicator of cytokinesis protein 7 isoform X4
dedicator of cytokinesis protein 7 isoform X5
dedicator of cytokinesis protein 7 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
KN motif and ankyrin repeat domains 4, transcript variant X2
KN motif and ankyrin repeat domains 4, transcript variant X4
KN motif and ankyrin repeat domains 4, transcript variant X6
KN motif and ankyrin repeat domains 4, transcript variant X1
KN motif and ankyrin repeat domains 4, transcript variant X3
KN motif and ankyrin repeat domains 4, transcript variant X5
KN motif and ankyrin repeat domain-containing protein 4
PATJ crumbs cell polarity complex component
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear factor I A, transcript variant X3
nuclear factor I A, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear factor I A, transcript variant X7
nuclear factor I A, transcript variant X10
nuclear factor I A, transcript variant X12
nuclear factor I A, transcript variant X2
nuclear factor I A, transcript variant X1
nuclear factor I A, transcript variant X6
nuclear factor I A, transcript variant X5
nuclear factor I A, transcript variant X14
nuclear factor I A, transcript variant X13
nuclear factor I A, transcript variant X9
nuclear factor I A, transcript variant X8
nuclear factor I A, transcript variant X4
uncharacterized LOC116491688, transcript variant X1
uncharacterized LOC116491688, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 11% coverage of the annotated genomic feature by RNAseq alignments
FGGY carbohydrate kinase domain containing, transcript variant X1
FGGY carbohydrate kinase domain containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FGGY carbohydrate kinase domain containing, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
FGGY carbohydrate kinase domain-containing protein isoform X1
FGGY carbohydrate kinase domain-containing protein isoform X2
Jun proto-oncogene, AP-1 transcription factor subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
metalloendopeptidase OMA1, mitochondrial
DAB adaptor protein 1, transcript variant X3
DAB adaptor protein 1, transcript variant X1
DAB adaptor protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DAB adaptor protein 1, transcript variant X5
DAB adaptor protein 1, transcript variant X2
DAB adaptor protein 1, transcript variant X7
DAB adaptor protein 1, transcript variant X8
DAB adaptor protein 1, transcript variant X9
DAB adaptor protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 8% coverage of the annotated genomic feature by RNAseq alignments
protein kinase AMP-activated catalytic subunit alpha 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
5'-AMP-activated protein kinase catalytic subunit alpha-2
ubiquitin specific peptidase 24, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ubiquitin specific peptidase 24, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 24 isoform X1
ubiquitin carboxyl-terminal hydrolase 24 isoform X2
proprotein convertase subtilisin/kexin type 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
probable proline--tRNA ligase, mitochondrial
acyl-CoA thioesterase 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acyl-CoA thioesterase 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acyl-coenzyme A thioesterase 11 isoform X1
acyl-coenzyme A thioesterase 11 isoform X2
single stranded DNA binding protein 3, transcript variant X1
single stranded DNA binding protein 3, transcript variant X2
single-stranded DNA-binding protein 3 isoform X1
single-stranded DNA-binding protein 3 isoform X2
single stranded DNA binding protein 3, transcript variant X3
single-stranded DNA-binding protein 3 isoform X3
39S ribosomal protein L37, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: CUB domain-containing protein 2
transcription elongation factor A N-terminal and central domain containing 2
transcription elongation factor A N-terminal and central domain-containing protein 2
transmembrane protein 59, transcript variant X1
transmembrane protein 59, transcript variant X2
low density lipoprotein receptor class A domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
low-density lipoprotein receptor class A domain-containing protein 1
leucine rich repeat containing 42, transcript variant X2
leucine rich repeat containing 42, transcript variant X3
leucine rich repeat containing 42, transcript variant X1
leucine-rich repeat-containing protein 42
heat shock protein family B (small) member 11
intraflagellar transport protein 25 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Yip1 domain family member 1, transcript variant X1
Yip1 domain family member 1, transcript variant X2
Yip1 domain family member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
DMRT like family B with proline rich C-terminal 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
doublesex- and mab-3-related transcription factor B1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
low-density lipoprotein receptor-related protein 8
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mago homolog, exon junction complex subunit
CXXC motif containing zinc binding protein, transcript variant X1
CXXC motif containing zinc binding protein, transcript variant X2
CXXC motif containing zinc binding protein isoform X1
CXXC motif containing zinc binding protein isoform X2
CXXC motif containing zinc binding protein, transcript variant X3
CXXC motif containing zinc binding protein isoform X3
carnitine O-palmitoyltransferase 2, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins
enoyl-CoA hydratase domain-containing protein 2, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
terminal uridylyl transferase 4, transcript variant X2
terminal uridylyl transferase 4, transcript variant X1
terminal uridylyl transferase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
terminal uridylyltransferase 4 isoform X1
terminal uridylyltransferase 4 isoform X2
terminal uridylyltransferase 4 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
coiled-coil and C2 domain-containing protein 1B
zinc finger FYVE-type containing 9, transcript variant X3
zinc finger FYVE-type containing 9, transcript variant X5
zinc finger FYVE-type containing 9, transcript variant X1
zinc finger FYVE-type containing 9, transcript variant X2
zinc finger FYVE-type containing 9, transcript variant X4
zinc finger FYVE domain-containing protein 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
thioredoxin domain-containing protein 12
RAB3B, member RAS oncogene family, transcript variant X2
RAB3B, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
oxysterol binding protein like 9, transcript variant X1
oxysterol binding protein like 9, transcript variant X3
oxysterol binding protein like 9, transcript variant X2
oxysterol binding protein like 9, transcript variant X4
oxysterol-binding protein-related protein 9 isoform X3
oxysterol-binding protein-related protein 9 isoform X1
oxysterol-binding protein-related protein 9 isoform X2
oxysterol-binding protein-related protein 9 isoform X4
epidermal growth factor receptor pathway substrate 15, transcript variant X3
epidermal growth factor receptor pathway substrate 15, transcript variant X1
epidermal growth factor receptor pathway substrate 15, transcript variant X6
epidermal growth factor receptor pathway substrate 15, transcript variant X2
epidermal growth factor receptor pathway substrate 15, transcript variant X4
epidermal growth factor receptor pathway substrate 15, transcript variant X5
epidermal growth factor receptor substrate 15 isoform X1
epidermal growth factor receptor substrate 15 isoform X2
epidermal growth factor receptor substrate 15 isoform X3
epidermal growth factor receptor substrate 15 isoform X4
epidermal growth factor receptor substrate 15 isoform X5
epidermal growth factor receptor substrate 15 isoform X6
tetratricopeptide repeat domain 39A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tetratricopeptide repeat domain 39A, transcript variant X1
tetratricopeptide repeat protein 39A isoform X1
tetratricopeptide repeat domain 39A, transcript variant X3
tetratricopeptide repeat protein 39A isoform X2
Fas associated factor 1, transcript variant X2
Fas associated factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: doublesex- and mab-3-related transcription factor A2
ELAV like RNA binding protein 4, transcript variant X4
ELAV like RNA binding protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ELAV like RNA binding protein 4, transcript variant X1
ELAV like RNA binding protein 4, transcript variant X9
ELAV like RNA binding protein 4, transcript variant X7
ELAV like RNA binding protein 4, transcript variant X8
ELAV like RNA binding protein 4, transcript variant X5
ELAV like RNA binding protein 4, transcript variant X10
ELAV like RNA binding protein 4, transcript variant X15
ELAV like RNA binding protein 4, transcript variant X6
ELAV like RNA binding protein 4, transcript variant X2
ELAV like RNA binding protein 4, transcript variant X13
ELAV like RNA binding protein 4, transcript variant X12
ELAV like RNA binding protein 4, transcript variant X11
ELAV like RNA binding protein 4, transcript variant X14
BEN domain containing 5, transcript variant X2
BEN domain containing 5, transcript variant X4
BEN domain containing 5, transcript variant X3
BEN domain-containing protein 5 isoform X2
BEN domain-containing protein 5 isoform X4
BEN domain-containing protein 5 isoform X3
BEN domain containing 5, transcript variant X1
BEN domain-containing protein 5 isoform X1
BEN domain containing 5, transcript variant X5
BEN domain containing 5, transcript variant X7
BEN domain-containing protein 5 isoform X5
BEN domain containing 5, transcript variant X6
BEN domain-containing protein 5 isoform X6
BEN domain containing 5, transcript variant X8
BEN domain containing 5, transcript variant X9
BEN domain-containing protein 5 isoform X7
BEN domain-containing protein 5 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: forkhead box protein D2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
TAL bHLH transcription factor 1, erythroid differentiation factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
T-cell acute lymphocytic leukemia protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 38% coverage of the annotated genomic feature by RNAseq alignments
EF-hand calcium-binding domain-containing protein 14
ATP synthase mitochondrial F1 complex assembly factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ATP synthase mitochondrial F1 complex assembly factor 1 isoform X1
ATP synthase mitochondrial F1 complex assembly factor 1, transcript variant X2
ATP synthase mitochondrial F1 complex assembly factor 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MAPK interacting serine/threonine kinase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MAP kinase-interacting serine/threonine-protein kinase 1
transmembrane protein 275, transcript variant X2
transmembrane protein 275, transcript variant X1
diencephalon/mesencephalon homeobox 1, transcript variant X2
diencephalon/mesencephalon homeobox 1, transcript variant X1
diencephalon/mesencephalon homeobox protein 1 isoform X2
diencephalon/mesencephalon homeobox protein 1 isoform X1
vitamin D3 hydroxylase-associated protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
vitamin D3 hydroxylase-associated protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 4% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
5-methylcytosine rRNA methyltransferase NSUN4
cytochrome b-c1 complex subunit 6, mitochondrial
leucine-rich repeat-containing protein 41
DNA repair and recombination protein RAD54-like isoform X1
DNA repair and recombination protein RAD54-like isoform X2
protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-), transcript variant X3
protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 isoform X2
protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-), transcript variant X1
protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol 3-kinase regulatory subunit gamma, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1
phosphatidylinositol 3-kinase regulatory subunit gamma, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphatidylinositol 3-kinase regulatory subunit gamma isoform X2
microtubule associated serine/threonine kinase 2, transcript variant X2
microtubule associated serine/threonine kinase 2, transcript variant X1
microtubule associated serine/threonine kinase 2, transcript variant X3
microtubule associated serine/threonine kinase 2, transcript variant X7
microtubule associated serine/threonine kinase 2, transcript variant X4
microtubule associated serine/threonine kinase 2, transcript variant X5
microtubule associated serine/threonine kinase 2, transcript variant X8
microtubule associated serine/threonine kinase 2, transcript variant X6
microtubule-associated serine/threonine-protein kinase 2 isoform X3
microtubule-associated serine/threonine-protein kinase 2 isoform X2
microtubule-associated serine/threonine-protein kinase 2 isoform X1
microtubule-associated serine/threonine-protein kinase 2 isoform X7
microtubule-associated serine/threonine-protein kinase 2 isoform X4
microtubule-associated serine/threonine-protein kinase 2 isoform X8
microtubule-associated serine/threonine-protein kinase 2 isoform X5
microtubule-associated serine/threonine-protein kinase 2 isoform X6
riboflavin-binding protein, transcript variant X2
riboflavin-binding protein, transcript variant X3
riboflavin-binding protein, transcript variant X1
riboflavin-binding protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
intracisternal A particle-promoted polypeptide
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GC-rich promoter binding protein 1 like 1
nuclear autoantigenic sperm protein, transcript variant X2
nuclear autoantigenic sperm protein, transcript variant X1
nuclear autoantigenic sperm protein isoform X2
nuclear autoantigenic sperm protein isoform X1
aldo-keto reductase family 1 member A1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aldo-keto reductase family 1 member A1, transcript variant X1
aldo-keto reductase family 1 member A1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aldo-keto reductase family 1 member A1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
methylmalonic aciduria and homocystinuria type C protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
testis associated actin remodelling kinase 2
dual specificity testis-specific protein kinase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
4-hydroxyphenylpyruvate dioxygenase like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
4-hydroxyphenylpyruvate dioxygenase-like protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: zinc finger SWIM domain-containing protein 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
HECT domain E3 ubiquitin protein ligase 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 2B subunit gamma
translation initiation factor eIF-2B subunit gamma
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 61% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: BTB/POZ domain-containing protein 19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00566
COORDINATES: nucleotide motif:Rfam:12.0:RF00212
COORDINATES: nucleotide motif:Rfam:12.0:RF00218
COORDINATES: nucleotide motif:Rfam:12.0:RF00157
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
kinesin family member 2C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
kinesin family member 2C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
armadillo like helical domain containing 1
armadillo-like helical domain containing protein 1
ring finger protein 220, transcript variant X2
ring finger protein 220, transcript variant X1
ring finger protein 220, transcript variant X4
ring finger protein 220, transcript variant X3
E3 ubiquitin-protein ligase RNF220 isoform X2
E3 ubiquitin-protein ligase RNF220 isoform X1
E3 ubiquitin-protein ligase RNF220 isoform X4
E3 ubiquitin-protein ligase RNF220 isoform X3
ERI1 exoribonuclease family member 3, transcript variant X2
ERI1 exoribonuclease family member 3, transcript variant X1
DNA methyltransferase 1 associated protein 1
DNA methyltransferase 1-associated protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 6 member 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sodium- and chloride-dependent glycine transporter 1 isoform X2
solute carrier family 6 member 9, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 6 member 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 6 member 9, transcript variant X1
solute carrier family 6 member 9, transcript variant X3
sodium- and chloride-dependent glycine transporter 1 isoform X1
sodium- and chloride-dependent glycine transporter 1 isoform X3
sodium- and chloride-dependent glycine transporter 1 isoform X4
V-type proton ATPase 21 kDa proteolipid subunit
2-(3-amino-3-carboxypropyl)histidine synthase subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
ST3 beta-galactoside alpha-2,3-sialyltransferase 3, transcript variant X3
ST3 beta-galactoside alpha-2,3-sialyltransferase 3, transcript variant X2
ST3 beta-galactoside alpha-2,3-sialyltransferase 3, transcript variant X1
CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase isoform X3
CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase isoform X2
CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase receptor type F, transcript variant X17
protein tyrosine phosphatase receptor type F, transcript variant X12
protein tyrosine phosphatase receptor type F, transcript variant X16
protein tyrosine phosphatase receptor type F, transcript variant X10
protein tyrosine phosphatase receptor type F, transcript variant X9
protein tyrosine phosphatase receptor type F, transcript variant X4
protein tyrosine phosphatase receptor type F, transcript variant X15
protein tyrosine phosphatase receptor type F, transcript variant X14
protein tyrosine phosphatase receptor type F, transcript variant X11
protein tyrosine phosphatase receptor type F, transcript variant X6
protein tyrosine phosphatase receptor type F, transcript variant X13
protein tyrosine phosphatase receptor type F, transcript variant X8
protein tyrosine phosphatase receptor type F, transcript variant X5
protein tyrosine phosphatase receptor type F, transcript variant X7
protein tyrosine phosphatase receptor type F, transcript variant X1
protein tyrosine phosphatase receptor type F, transcript variant X2
protein tyrosine phosphatase receptor type F, transcript variant X3
receptor-type tyrosine-protein phosphatase F isoform X15
receptor-type tyrosine-protein phosphatase F isoform X10
receptor-type tyrosine-protein phosphatase F isoform X14
receptor-type tyrosine-protein phosphatase F isoform X8
receptor-type tyrosine-protein phosphatase F isoform X7
receptor-type tyrosine-protein phosphatase F isoform X2
receptor-type tyrosine-protein phosphatase F isoform X13
receptor-type tyrosine-protein phosphatase F isoform X12
receptor-type tyrosine-protein phosphatase F isoform X9
receptor-type tyrosine-protein phosphatase F isoform X4
receptor-type tyrosine-protein phosphatase F isoform X11
receptor-type tyrosine-protein phosphatase F isoform X6
receptor-type tyrosine-protein phosphatase F isoform X3
receptor-type tyrosine-protein phosphatase F isoform X5
receptor-type tyrosine-protein phosphatase F isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
mediator of RNA polymerase II transcription subunit 8
ELOVL fatty acid elongase 1, transcript variant X2
ELOVL fatty acid elongase 1, transcript variant X1
elongation of very long chain fatty acids protein 1
MPL proto-oncogene, thrombopoietin receptor
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: thrombopoietin receptor
tyrosine kinase with immunoglobulin like and EGF like domains 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 125, transcript variant X2
transmembrane protein 125, transcript variant X1
cilia and flagella associated protein 57
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
cilia- and flagella-associated protein 57
family with sequence similarity 183 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5
phosphatidylinositol glycan anchor biosynthesis class K, transcript variant X1
phosphatidylinositol glycan anchor biosynthesis class K, transcript variant X2
zinc finger ZZ-type containing 3, transcript variant X3
zinc finger ZZ-type containing 3, transcript variant X4
zinc finger ZZ-type containing 3, transcript variant X1
zinc finger ZZ-type containing 3, transcript variant X2
ZZ-type zinc finger-containing protein 3 isoform X2
ZZ-type zinc finger-containing protein 3 isoform X1
ubiquitin specific peptidase 33, transcript variant X4
ubiquitin specific peptidase 33, transcript variant X5
ubiquitin specific peptidase 33, transcript variant X2
ubiquitin specific peptidase 33, transcript variant X1
ubiquitin specific peptidase 33, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 33 isoform X3
ubiquitin carboxyl-terminal hydrolase 33 isoform X2
ubiquitin carboxyl-terminal hydrolase 33 isoform X1
ubiquitin carboxyl-terminal hydrolase 33 isoform X4
nexilin F-actin binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nexilin F-actin binding protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nexilin F-actin binding protein, transcript variant X6
nexilin F-actin binding protein, transcript variant X5
nexilin F-actin binding protein, transcript variant X1
nexilin F-actin binding protein, transcript variant X4
far upstream element binding protein 1, transcript variant X3
far upstream element binding protein 1, transcript variant X5
far upstream element binding protein 1, transcript variant X1
far upstream element binding protein 1, transcript variant X4
far upstream element-binding protein 1 isoform X5
far upstream element-binding protein 1 isoform X4
far upstream element-binding protein 1 isoform X3
far upstream element-binding protein 1 isoform X1
far upstream element binding protein 1, transcript variant X2
far upstream element-binding protein 1 isoform X2
DnaJ heat shock protein family (Hsp40) member B4, transcript variant X1
DnaJ heat shock protein family (Hsp40) member B4, transcript variant X2
GIPC PDZ domain containing family member 2, transcript variant X2
GIPC PDZ domain containing family member 2, transcript variant X1
PDZ domain-containing protein GIPC2 isoform X2
PDZ domain-containing protein GIPC2 isoform X1
prostaglandin F receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
prostaglandin F receptor, transcript variant X3
prostaglandin F receptor, transcript variant X2
prostaglandin F2-alpha receptor isoform X1
prostaglandin F2-alpha receptor isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
adhesion G protein-coupled receptor L4, transcript variant X2
adhesion G protein-coupled receptor L4, transcript variant X3
adhesion G protein-coupled receptor L4, transcript variant X1
adhesion G protein-coupled receptor L4 isoform X2
adhesion G protein-coupled receptor L4 isoform X3
adhesion G protein-coupled receptor L4 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: adhesion G protein-coupled receptor L2
tubulin tyrosine ligase like 7, transcript variant X5
tubulin tyrosine ligase like 7, transcript variant X2
tubulin tyrosine ligase like 7, transcript variant X4
tubulin tyrosine ligase like 7, transcript variant X3
tubulin tyrosine ligase like 7, transcript variant X1
tubulin tyrosine ligase like 7, transcript variant X6
protein kinase cAMP-activated catalytic subunit beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein kinase cAMP-activated catalytic subunit beta, transcript variant X2
cAMP-dependent protein kinase catalytic subunit beta isoform X1
cAMP-dependent protein kinase catalytic subunit beta isoform X2
sterile alpha motif domain containing 13, transcript variant X3
sterile alpha motif domain containing 13, transcript variant X1
sterile alpha motif domain containing 13, transcript variant X2
sterile alpha motif domain-containing protein 13
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
afadin- and alpha-actinin-binding protein
lysophosphatidic acid receptor 3, transcript variant X1
lysophosphatidic acid receptor 3, transcript variant X5
lysophosphatidic acid receptor 3, transcript variant X7
lysophosphatidic acid receptor 3, transcript variant X3
lysophosphatidic acid receptor 3, transcript variant X6
lysophosphatidic acid receptor 3, transcript variant X2
lysophosphatidic acid receptor 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 13% coverage of the annotated genomic feature by RNAseq alignments
BCL10 immune signaling adaptor, transcript variant X1
BCL10 immune signaling adaptor, transcript variant X2
dimethylarginine dimethylaminohydrolase 1, transcript variant X2
dimethylarginine dimethylaminohydrolase 1, transcript variant X1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 isoform X1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
collagen type XXIV alpha 1 chain, transcript variant X2
collagen type XXIV alpha 1 chain, transcript variant X1
collagen type XXIV alpha 1 chain, transcript variant X3
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; substituted 4 bases at 4 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: calcium-activated chloride channel regulator 2
calcium-activated chloride channel regulator 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins
SH3 domain containing GRB2 like, endophilin B1, transcript variant X1
SH3 domain containing GRB2 like, endophilin B1, transcript variant X2
SH3 domain containing GRB2 like, endophilin B1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC116491668, transcript variant X1
uncharacterized LOC116491668, transcript variant X2
uncharacterized LOC116491668, transcript variant X3
uncharacterized LOC116491686, transcript variant X2
uncharacterized LOC116491686, transcript variant X1
protein kinase N2, transcript variant X1
serine/threonine-protein kinase N2 isoform X1
protein kinase N2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase N2 isoform X2
general transcription factor IIB, transcript variant X1
general transcription factor IIB, transcript variant X3
general transcription factor IIB, transcript variant X2
transcription initiation factor IIB isoform X1
transcription initiation factor IIB isoform X2
kynurenine aminotransferase 3, transcript variant X1
kynurenine aminotransferase 3, transcript variant X2
kynurenine--oxoglutarate transaminase 3 isoform X1
kynurenine--oxoglutarate transaminase 3 isoform X2
leucine rich repeat containing 8 VRAC subunit B
volume-regulated anion channel subunit LRRC8B
leucine rich repeat containing 8 VRAC subunit C, transcript variant X1
leucine rich repeat containing 8 VRAC subunit C, transcript variant X2
volume-regulated anion channel subunit LRRC8C
leucine rich repeat containing 8 VRAC subunit D, transcript variant X5
leucine rich repeat containing 8 VRAC subunit D, transcript variant X3
leucine rich repeat containing 8 VRAC subunit D, transcript variant X1
volume-regulated anion channel subunit LRRC8D isoform X1
leucine rich repeat containing 8 VRAC subunit D, transcript variant X2
leucine rich repeat containing 8 VRAC subunit D, transcript variant X4
volume-regulated anion channel subunit LRRC8D isoform X2
zinc finger protein 326, transcript variant X1
zinc finger protein 326, transcript variant X2
ral guanine nucleotide dissociation stimulator like 1
ral guanine nucleotide dissociation stimulator-like 1
collagen beta(1-O)galactosyltransferase 2, transcript variant X3
collagen beta(1-O)galactosyltransferase 2, transcript variant X1
collagen beta(1-O)galactosyltransferase 2, transcript variant X2
collagen beta(1-O)galactosyltransferase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tRNA-splicing endonuclease subunit Sen15
chromosome 8 C1orf21 homolog, transcript variant X1
chromosome 8 C1orf21 homolog, transcript variant X2
ER degradation enhancing alpha-mannosidase like protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ER degradation enhancing alpha-mannosidase like protein 3, transcript variant X3
ER degradation enhancing alpha-mannosidase like protein 3, transcript variant X2
ER degradation-enhancing alpha-mannosidase-like protein 3 isoform X1
ER degradation-enhancing alpha-mannosidase-like protein 3 isoform X3
ER degradation-enhancing alpha-mannosidase-like protein 3 isoform X2
ring finger protein 2, transcript variant X1
ring finger protein 2, transcript variant X2
tRNA methyltransferase 1 like, transcript variant X2
tRNA methyltransferase 1 like, transcript variant X1
SWT1 RNA endoribonuclease homolog, transcript variant X2
SWT1 RNA endoribonuclease homolog, transcript variant X1
SWT1 RNA endoribonuclease homolog, transcript variant X3
influenza virus NS1A binding protein, transcript variant X2
influenza virus NS1A binding protein, transcript variant X3
influenza virus NS1A binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
translocated promoter region, nuclear basket protein, transcript variant X3
translocated promoter region, nuclear basket protein, transcript variant X2
translocated promoter region, nuclear basket protein, transcript variant X1
odr-4 GPCR localization factor homolog, transcript variant X2
odr-4 GPCR localization factor homolog, transcript variant X1
odr-4 GPCR localization factor homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BMP/retinoic acid inducible neural specific 3, transcript variant X1
BMP/retinoic acid inducible neural specific 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BMP/retinoic acid-inducible neural-specific protein 3
antigen-presenting glycoprotein CD1d-like
actin related protein 2/3 complex subunit 5
actin-related protein 2/3 complex subunit 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
SMG7 nonsense mediated mRNA decay factor, transcript variant X3
SMG7 nonsense mediated mRNA decay factor, transcript variant X4
SMG7 nonsense mediated mRNA decay factor, transcript variant X6
SMG7 nonsense mediated mRNA decay factor, transcript variant X5
SMG7 nonsense mediated mRNA decay factor, transcript variant X2
SMG7 nonsense mediated mRNA decay factor, transcript variant X1
nicotinamide nucleotide adenylyltransferase 2
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
N-acetylneuraminate pyruvate lyase, transcript variant X15
N-acetylneuraminate pyruvate lyase, transcript variant X8
N-acetylneuraminate pyruvate lyase, transcript variant X12
N-acetylneuraminate pyruvate lyase, transcript variant X10
N-acetylneuraminate pyruvate lyase, transcript variant X9
N-acetylneuraminate pyruvate lyase, transcript variant X11
N-acetylneuraminate pyruvate lyase, transcript variant X13
N-acetylneuraminate pyruvate lyase, transcript variant X7
N-acetylneuraminate pyruvate lyase, transcript variant X14
N-acetylneuraminate pyruvate lyase, transcript variant X5
N-acetylneuraminate pyruvate lyase, transcript variant X6
N-acetylneuraminate pyruvate lyase, transcript variant X16
N-acetylneuraminate pyruvate lyase, transcript variant X17
N-acetylneuraminate pyruvate lyase, transcript variant X1
N-acetylneuraminate pyruvate lyase, transcript variant X3
N-acetylneuraminate pyruvate lyase, transcript variant X4
N-acetylneuraminate pyruvate lyase, transcript variant X2
heme-binding protein 2-like, transcript variant X2
heme-binding protein 2-like, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00281
COORDINATES: nucleotide motif:Rfam:12.0:RF00152
COORDINATES: nucleotide motif:Rfam:12.0:RF00592
COORDINATES: nucleotide motif:Rfam:12.0:RF00287
small nucleolar RNA snR60/Z15/Z230/Z193/J17
COORDINATES: nucleotide motif:Rfam:12.0:RF00309
COORDINATES: nucleotide motif:Rfam:12.0:RF00069
COORDINATES: nucleotide motif:Rfam:12.0:RF00612
COORDINATES: nucleotide motif:Rfam:12.0:RF00284
zinc finger and BTB domain containing 37, transcript variant X1
zinc finger and BTB domain containing 37, transcript variant X3
zinc finger and BTB domain containing 37, transcript variant X2
zinc finger and BTB domain-containing protein 37 isoform X1
zinc finger and BTB domain-containing protein 37 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ring finger and CCCH-type domains 1, transcript variant X5
ring finger and CCCH-type domains 1, transcript variant X4
ring finger and CCCH-type domains 1, transcript variant X3
ring finger and CCCH-type domains 1, transcript variant X1
ring finger and CCCH-type domains 1, transcript variant X2
uncharacterized LOC116491777, transcript variant X1
uncharacterized LOC116491777, transcript variant X2
RAB GTPase activating protein 1 like, transcript variant X1
RAB GTPase activating protein 1 like, transcript variant X3
RAB GTPase activating protein 1 like, transcript variant X2
rab GTPase-activating protein 1-like isoform X1
rab GTPase-activating protein 1-like isoform X2
RAB GTPase activating protein 1 like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rab GTPase-activating protein 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
RAB GTPase activating protein 1 like, transcript variant X5
rab GTPase-activating protein 1-like isoform X4
RAB GTPase activating protein 1 like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
rab GTPase-activating protein 1-like isoform X5
RAB GTPase activating protein 1 like, transcript variant X7
rab GTPase-activating protein 1-like isoform X6
28S ribosomal protein S14, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein KIAA0040 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00565
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
BMP/retinoic acid inducible neural specific 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
BMP/retinoic acid-inducible neural-specific protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
RAS protein activator like 2, transcript variant X1
RAS protein activator like 2, transcript variant X2
RAS protein activator like 2, transcript variant X3
RAS protein activator like 2, transcript variant X4
ras GTPase-activating protein nGAP isoform X2
ras GTPase-activating protein nGAP isoform X4
ras GTPase-activating protein nGAP isoform X1
ras GTPase-activating protein nGAP isoform X3
RAS protein activator like 2, transcript variant X8
ras GTPase-activating protein nGAP isoform X8
RAS protein activator like 2, transcript variant X6
ras GTPase-activating protein nGAP isoform X6
RAS protein activator like 2, transcript variant X5
ras GTPase-activating protein nGAP isoform X5
RAS protein activator like 2, transcript variant X7
ras GTPase-activating protein nGAP isoform X7
Ral GEF with PH domain and SH3 binding motif 2, transcript variant X1
Ral GEF with PH domain and SH3 binding motif 2, transcript variant X3
Ral GEF with PH domain and SH3 binding motif 2, transcript variant X2
ras-specific guanine nucleotide-releasing factor RalGPS2 isoform X1
ras-specific guanine nucleotide-releasing factor RalGPS2 isoform X2
FAM20B glycosaminoglycan xylosylkinase, transcript variant X1
FAM20B glycosaminoglycan xylosylkinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ABL proto-oncogene 2, non-receptor tyrosine kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sterol O-acyltransferase 1, transcript variant X3
sterol O-acyltransferase 1, transcript variant X2
sterol O-acyltransferase 1, transcript variant X1
sterol O-acyltransferase 1, transcript variant X4
axonemal dynein light chain domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 2% coverage of the annotated genomic feature by RNAseq alignments
axonemal dynein light chain domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 163 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
torsin-1A-interacting protein 1-like, transcript variant X1
torsin-1A-interacting protein 1-like, transcript variant X2
torsin-1A-interacting protein 1-like isoform X1
torsin-1A-interacting protein 1-like isoform X2
centrosomal protein 350, transcript variant X2
centrosomal protein 350, transcript variant X1
centrosomal protein 350, transcript variant X5
centrosomal protein 350, transcript variant X4
centrosomal protein 350, transcript variant X6
centrosomal protein 350, transcript variant X3
centrosomal protein 350, transcript variant X7
centrosome-associated protein 350 isoform X1
centrosome-associated protein 350 isoform X4
centrosome-associated protein 350 isoform X3
centrosome-associated protein 350 isoform X5
centrosome-associated protein 350 isoform X2
centrosome-associated protein 350 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
acyl-CoA-binding domain-containing protein 6
xenotropic and polytropic retrovirus receptor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 23% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein KIAA1614 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
calcium voltage-gated channel subunit alpha1 E
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
voltage-dependent R-type calcium channel subunit alpha-1E
zinc finger protein 648, transcript variant X3
zinc finger protein 648, transcript variant X2
zinc finger protein 648, transcript variant X1
zinc finger protein 648, transcript variant X4
regulator of G-protein signaling protein-like
regulator of G protein signaling 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
regulator of G protein signaling 16, transcript variant X2
regulator of G-protein signaling 16 isoform X1
regulator of G-protein signaling 16 isoform X2
regulator of G protein signaling 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulator of G protein signaling 8, transcript variant X4
regulator of G protein signaling 8, transcript variant X2
regulator of G protein signaling 8, transcript variant X1
regulator of G-protein signaling 8 isoform X2
regulator of G-protein signaling 8 isoform X1
aspartyl-tRNA synthetase 2, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kelch like family member 20, transcript variant X1
kelch like family member 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aldehyde dehydrogenase 9 family member A1
4-trimethylaminobutyraldehyde dehydrogenase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeat-containing protein 52
NUF2 component of NDC80 kinetochore complex
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pre-B-cell leukemia transcription factor 1 isoform X1
pre-B-cell leukemia transcription factor 1 isoform X2
LIM homeobox transcription factor 1 alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
LIM homeobox transcription factor 1-alpha
14 kDa phosphohistidine phosphatase-like, transcript variant X2
14 kDa phosphohistidine phosphatase-like, transcript variant X1
14 kDa phosphohistidine phosphatase-like
histidine protein methyltransferase 1 homolog
uncharacterized protein C1orf112 homolog
protein-associating with the carboxyl-terminal domain of ezrin
kinesin associated protein 3, transcript variant X1
kinesin associated protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
alpha N-terminal protein methyltransferase 1B
golgin, RAB6 interacting, transcript variant X1
golgin, RAB6 interacting, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
dimethylaniline monooxygenase [N-oxide-forming] 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dimethylaniline monooxygenase [N-oxide-forming] 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dimethylaniline monooxygenase [N-oxide-forming] 3-like
dimethylaniline monooxygenase [N-oxide-forming] 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
proline rich coiled-coil 2C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
proline rich coiled-coil 2C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
proline rich coiled-coil 2C, transcript variant X6
proline rich coiled-coil 2C, transcript variant X5
proline rich coiled-coil 2C, transcript variant X7
proline rich coiled-coil 2C, transcript variant X3
proline rich coiled-coil 2C, transcript variant X8
proline rich coiled-coil 2C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
eEF1A lysine and N-terminal methyltransferase
phosphatidylinositol glycan anchor biosynthesis class C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol N-acetylglucosaminyltransferase subunit C
SUN domain containing ossification factor, transcript variant X2
SUN domain containing ossification factor, transcript variant X3
SUN domain containing ossification factor, transcript variant X4
SUN domain containing ossification factor, transcript variant X1
SUN domain-containing ossification factor isoform X1
SUN domain-containing ossification factor isoform X2
SUN domain-containing ossification factor isoform X3
SUN domain-containing ossification factor isoform X4
tumor necrosis factor ligand superfamily member 6
family with sequence similarity 78 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phospholipid phosphatase 6, transcript variant X1
phospholipid phosphatase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dimethylaniline monooxygenase [N-oxide-forming] 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
protein kinase AMP-activated non-catalytic subunit beta 2, transcript variant X1
protein kinase AMP-activated non-catalytic subunit beta 2, transcript variant X2
5'-AMP-activated protein kinase subunit beta-2 isoform X1
5'-AMP-activated protein kinase subunit beta-2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
3-hydroxy-3-methylglutaryl-CoA synthase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
hydroxymethylglutaryl-CoA synthase, mitochondrial
neurogenic locus notch homolog protein 2
SEC22 homolog B, vesicle trafficking protein
phosphofurin acidic cluster sorting protein 2, transcript variant X1
phosphofurin acidic cluster sorting protein 2 isoform X1
phosphofurin acidic cluster sorting protein 2, transcript variant X5
phosphofurin acidic cluster sorting protein 2, transcript variant X2
phosphofurin acidic cluster sorting protein 2, transcript variant X6
phosphofurin acidic cluster sorting protein 2, transcript variant X3
phosphofurin acidic cluster sorting protein 2, transcript variant X4
phosphofurin acidic cluster sorting protein 2, transcript variant X7
phosphofurin acidic cluster sorting protein 2 isoform X5
phosphofurin acidic cluster sorting protein 2 isoform X2
phosphofurin acidic cluster sorting protein 2 isoform X6
phosphofurin acidic cluster sorting protein 2 isoform X3
phosphofurin acidic cluster sorting protein 2 isoform X4
phosphofurin acidic cluster sorting protein 2 isoform X7
metastasis associated 1, transcript variant X1
metastasis associated 1, transcript variant X2
metastasis associated 1, transcript variant X3
metastasis-associated protein MTA1 isoform X1
metastasis-associated protein MTA1 isoform X2
metastasis-associated protein MTA1 isoform X3
tubulin epsilon and delta complex protein 1
nitric oxide synthase 1 adaptor protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
nitric oxide synthase 1 adaptor protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein isoform X1
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 25% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C1orf226 homolog
UDP-N-acetylglucosamine pyrophosphorylase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
UDP-N-acetylhexosamine pyrophosphorylase
discoidin domain receptor tyrosine kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
discoidin domain-containing receptor 2 isoform X2
discoidin domain receptor tyrosine kinase 2, transcript variant X1
discoidin domain-containing receptor 2 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: olfactomedin-like protein 2B
activating transcription factor 6, transcript variant X2
activating transcription factor 6, transcript variant X1
cyclic AMP-dependent transcription factor ATF-6 alpha isoform X2
cyclic AMP-dependent transcription factor ATF-6 alpha isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
1-phosphatidylinositol phosphodiesterase-like
regulator of G protein signaling 5, transcript variant X1
regulator of G protein signaling 5, transcript variant X2
regulator of G-protein signaling 5 isoform X1
regulator of G-protein signaling 5 isoform X2
regulator of G protein signaling 5, transcript variant X3
regulator of G-protein signaling 5 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
regulator of G-protein signaling 18-like
ubiquitin carboxyl-terminal hydrolase isozyme L5
beta-1,3-galactosyltransferase 2, transcript variant X1
beta-1,3-galactosyltransferase 2, transcript variant X2
uncharacterized LOC116491704, transcript variant X1
uncharacterized LOC116491704, transcript variant X3
uncharacterized LOC116491704, transcript variant X2
potassium sodium-activated channel subfamily T member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium sodium-activated channel subfamily T member 2, transcript variant X2
potassium sodium-activated channel subfamily T member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium channel subfamily T member 2 isoform X3
potassium channel subfamily T member 2 isoform X2
potassium channel subfamily T member 2 isoform X1
potassium sodium-activated channel subfamily T member 2, transcript variant X4
potassium channel subfamily T member 2 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 40% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
assembly factor for spindle microtubules
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: abnormal spindle-like microcephaly-associated protein
zinc finger and BTB domain containing 41, transcript variant X2
zinc finger and BTB domain containing 41, transcript variant X3
zinc finger and BTB domain containing 41, transcript variant X1
zinc finger and BTB domain-containing protein 41
crumbs cell polarity complex component 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
DENN domain containing 1B, transcript variant X1
DENN domain containing 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
DENN domain-containing protein 1B isoform X1
DENN domain-containing protein 1B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
protein tyrosine phosphatase receptor type C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
receptor-type tyrosine-protein phosphatase C
nuclear receptor subfamily 5 group A member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
probable ATP-dependent RNA helicase DDX59
calmodulin regulated spectrin associated protein family member 2, transcript variant X1
calmodulin regulated spectrin associated protein family member 2, transcript variant X2
calmodulin-regulated spectrin-associated protein 2 isoform X1
calmodulin-regulated spectrin-associated protein 2 isoform X2
calmodulin regulated spectrin associated protein family member 2, transcript variant X3
calmodulin-regulated spectrin-associated protein 2 isoform X3
WD repeat domain 47, transcript variant X3
WD repeat domain 47, transcript variant X1
WD repeat domain 47, transcript variant X2
WD repeat-containing protein 47 isoform X1
WD repeat-containing protein 47 isoform X2
G protein signaling modulator 2, transcript variant X2
G protein signaling modulator 2, transcript variant X1
AKNA domain containing 1, transcript variant X1
AKNA domain containing 1, transcript variant X2
AKNA domain containing 1, transcript variant X4
AKNA domain containing 1, transcript variant X3
fibronectin type III domain containing 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
fibronectin type III domain-containing protein 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 102 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein SCaMC-1
vav guanine nucleotide exchange factor 3, transcript variant X1
vav guanine nucleotide exchange factor 3, transcript variant X2
guanine nucleotide exchange factor VAV3 isoform X1
guanine nucleotide exchange factor VAV3 isoform X2
uncharacterized LOC116492017, transcript variant X1
uncharacterized LOC116492017, transcript variant X2
uncharacterized LOC116492018, transcript variant X1
uncharacterized LOC116492018, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 32% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
pancreatic alpha-amylase-like, transcript variant X2
pancreatic alpha-amylase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pancreatic alpha-amylase-like isoform X2
pancreatic alpha-amylase-like isoform X1
RNA binding region (RNP1, RRM) containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RNA binding region (RNP1, RRM) containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
collagen type XI alpha 1 chain, transcript variant X2
collagen type XI alpha 1 chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized oxidoreductase ZK1290.5-like
exostosin like glycosyltransferase 2, transcript variant X2
exostosin like glycosyltransferase 2, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dual specificity protein phosphatase CDC14A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
dihydrolipoamide branched chain transacylase E2
lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial
leucine rich repeat containing 39, transcript variant X2
leucine rich repeat containing 39, transcript variant X1
leucine-rich repeat-containing protein 39
tRNA:m(4)X modification enzyme TRM13 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
spindle assembly abnormal protein 6 homolog
major facilitator superfamily domain containing 14A
hippocampus abundant transcript 1 protein
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase, transcript variant X1
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase, transcript variant X2
phospholipid phosphatase-related protein type 4
phospholipid phosphatase related 5, transcript variant X3
phospholipid phosphatase-related protein type 5 isoform X2
phospholipid phosphatase related 5, transcript variant X1
phospholipid phosphatase related 5, transcript variant X2
phospholipid phosphatase related 5, transcript variant X5
phospholipid phosphatase related 5, transcript variant X4
phospholipid phosphatase-related protein type 5 isoform X1
phospholipid phosphatase-related protein type 5 isoform X3
uncharacterized LOC116491842, transcript variant X2
uncharacterized LOC116491842, transcript variant X1
uncharacterized LOC116491842, transcript variant X5
uncharacterized LOC116491842, transcript variant X3
uncharacterized LOC116491842, transcript variant X4
dihydropyrimidine dehydrogenase, transcript variant X1
dihydropyrimidine dehydrogenase, transcript variant X2
dihydropyrimidine dehydrogenase, transcript variant X3
dihydropyrimidine dehydrogenase, transcript variant X4
dihydropyrimidine dehydrogenase [NADP(+)] isoform X1
dihydropyrimidine dehydrogenase [NADP(+)] isoform X2
dihydropyrimidine dehydrogenase [NADP(+)] isoform X3
dihydropyrimidine dehydrogenase [NADP(+)] isoform X4
uncharacterized LOC116491844, transcript variant X3
uncharacterized LOC116491844, transcript variant X1
uncharacterized LOC116491844, transcript variant X2
polypyrimidine tract binding protein 2, transcript variant X5
polypyrimidine tract binding protein 2, transcript variant X4
polypyrimidine tract binding protein 2, transcript variant X3
polypyrimidine tract binding protein 2, transcript variant X2
polypyrimidine tract binding protein 2, transcript variant X1
polypyrimidine tract-binding protein 2 isoform X4
polypyrimidine tract-binding protein 2 isoform X3
polypyrimidine tract-binding protein 2 isoform X2
polypyrimidine tract-binding protein 2 isoform X1
polypyrimidine tract-binding protein 2 isoform X5
RWD domain containing 3, transcript variant X1
RWD domain containing 3, transcript variant X2
RWD domain-containing protein 3 isoform X1
RWD domain-containing protein 3 isoform X2
TLC domain containing 4, transcript variant X1
TLC domain containing 4, transcript variant X2
ALG14 UDP-N-acetylglucosaminyltransferase subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
UDP-N-acetylglucosamine transferase subunit ALG14 homolog
solute carrier family 44 member 3, transcript variant X4
solute carrier family 44 member 3, transcript variant X2
solute carrier family 44 member 3, transcript variant X1
solute carrier family 44 member 3, transcript variant X3
choline transporter-like protein 3 isoform X2
choline transporter-like protein 3 isoform X1
choline transporter-like protein 3 isoform X4
choline transporter-like protein 3 isoform X3
ATP binding cassette subfamily D member 3
ATP-binding cassette sub-family D member 3
Rho GTPase activating protein 29, transcript variant X1
Rho GTPase activating protein 29, transcript variant X4
Rho GTPase activating protein 29, transcript variant X3
Rho GTPase activating protein 29, transcript variant X2
rho GTPase-activating protein 29 isoform X1
rho GTPase-activating protein 29 isoform X3
rho GTPase-activating protein 29 isoform X2
Rho GTPase activating protein 29, transcript variant X5
rho GTPase-activating protein 29 isoform X4
ATP binding cassette subfamily A member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
retinal-specific phospholipid-transporting ATPase ABCA4
trans-2,3-enoyl-CoA reductase, transcript variant X2
trans-2,3-enoyl-CoA reductase, transcript variant X1
very-long-chain enoyl-CoA reductase isoform X1
very-long-chain enoyl-CoA reductase isoform X2
trans-2,3-enoyl-CoA reductase, transcript variant X3
very-long-chain enoyl-CoA reductase isoform X3
trans-2,3-enoyl-CoA reductase, transcript variant X4
glutamate-cysteine ligase modifier subunit
glutamate--cysteine ligase regulatory subunit
deoxynucleotidyltransferase terminal interacting protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
deoxynucleotidyltransferase terminal-interacting protein 2
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
BCAR3 adaptor protein, NSP family member, transcript variant X4
BCAR3 adaptor protein, NSP family member, transcript variant X1
breast cancer anti-estrogen resistance protein 3 isoform X1
BCAR3 adaptor protein, NSP family member, transcript variant X5
BCAR3 adaptor protein, NSP family member, transcript variant X2
BCAR3 adaptor protein, NSP family member, transcript variant X3
breast cancer anti-estrogen resistance protein 3 isoform X2
BCAR3 adaptor protein, NSP family member, transcript variant X6
breast cancer anti-estrogen resistance protein 3 isoform X3
formin binding protein 1 like, transcript variant X2
formin binding protein 1 like, transcript variant X3
formin binding protein 1 like, transcript variant X1
formin-binding protein 1-like isoform X2
formin-binding protein 1-like isoform X1
formin-binding protein 1-like isoform X3
coiled-coil domain containing 18, transcript variant X4
coiled-coil domain containing 18, transcript variant X2
coiled-coil domain containing 18, transcript variant X3
coiled-coil domain containing 18, transcript variant X1
coiled-coil domain-containing protein 18 isoform X4
coiled-coil domain-containing protein 18 isoform X2
coiled-coil domain-containing protein 18 isoform X3
coiled-coil domain-containing protein 18 isoform X1
transmembrane emp24 domain-containing protein 5
metal response element binding transcription factor 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: metal-response element-binding transcription factor 2
divergent protein kinase domain 1A, transcript variant X2
divergent protein kinase domain 1A, transcript variant X3
divergent protein kinase domain 1A, transcript variant X1
divergent protein kinase domain 1A isoform X2
divergent protein kinase domain 1A isoform X1
divergent protein kinase domain 1A isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00068
ecotropic viral integration site 5, transcript variant X4
ecotropic viral integration site 5, transcript variant X1
ecotropic viral integration site 5, transcript variant X3
ecotropic viral integration site 5, transcript variant X2
ecotropic viral integration site 5 protein homolog isoform X4
ecotropic viral integration site 5 protein homolog isoform X1
ecotropic viral integration site 5 protein homolog isoform X3
ecotropic viral integration site 5 protein homolog isoform X2
growth factor independent 1 transcriptional repressor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
growth factor independent 1 transcriptional repressor, transcript variant X1
putative RNA polymerase II subunit B1 CTD phosphatase RPAP2
glomulin, FKBP associated protein, transcript variant X1
glomulin, FKBP associated protein, transcript variant X3
glomulin, FKBP associated protein, transcript variant X2
glomulin, FKBP associated protein, transcript variant X4
uncharacterized protein C1orf146 homolog
BTB domain containing 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BTB domain containing 8, transcript variant X1
BTB domain containing 8, transcript variant X4
BTB domain containing 8, transcript variant X3
BTB/POZ domain-containing protein 8 isoform X1
BTB/POZ domain-containing protein 8 isoform X3
BTB/POZ domain-containing protein 8 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: bromodomain testis-specific protein
transforming growth factor beta receptor 3, transcript variant X1
transforming growth factor beta receptor 3, transcript variant X2
transforming growth factor beta receptor type 3
cell division cycle 7, transcript variant X2
cell division cycle 7, transcript variant X1
cell division cycle 7, transcript variant X3
cell division cycle 7-related protein kinase isoform X1
cell division cycle 7-related protein kinase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: probable ATP-dependent DNA helicase HFM1
zinc finger protein 644, transcript variant X2
zinc finger protein 644, transcript variant X3
zinc finger protein 644, transcript variant X5
zinc finger protein 644, transcript variant X7
zinc finger protein 644, transcript variant X1
zinc finger protein 644, transcript variant X8
zinc finger protein 644, transcript variant X4
zinc finger protein 644, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
uncharacterized LOC116491667, transcript variant X2
uncharacterized LOC116491667, transcript variant X1